Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review.

Qiukui HaoFarid ForoutanMi Ah HanTahira DevjiFernando Kenji NampoSudipto MukherjeeShabbir M H AlibhaiAshley RoskoMikkael A SekeresGordon H GuyattRomina Brignardello-Petersen

Published in: PloS one (2022)

High-quality or moderate-quality evidence support that age, comorbidities, performance status predicts the long-term prognosis of older patients with AML undergoing antileukemic treatment.

Keyphrases

newly diagnosed
acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
physical activity
middle aged
combination therapy
stem cells
mesenchymal stem cells
replacement therapy